Dr. Arbour on the Latest Data for Checkpoint Inhibitors for Lung Cancer in 2019

June 11, 2019

Cancer Network spoke with Kathryn Cecilia Arbour, MD, of Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in oncology.

Cancer Network spoke with Kathryn Cecilia Arbour, MD, medical oncologist at Memorial Sloan-Kettering Cancer Center, about the most recent research on checkpoint inhibitors in the treatment of cancer. Dr. Arbour presented this data during an educational session at ASCO 2019.